Table A2.
Cox proportional hazards model on the impact of laboratories measurements on in-hospital mortality. Confounding variables with a significance level of <0.1 were retained in the final model. n = 2217, death = 369.
| HR (95% CI) | p-Value | |
|---|---|---|
| CKD Stage (eGFR 30–59 mL/min vs. eGFR > 60 mL/min) | 1.162 (0.903–1.495) | 0.2420 |
| CKD Stage (eGFR < 30 mL/min vs. eGFR > 60 mL/min) | 1.621 (1.166–2.253) | 0.0041 |
| Age (years) | 1.057 (1.046–1.067) | <0.0001 |
| Sex (M vs. F) | 1.239 (0.978–1.568) | 0.0753 |
| Hemoglobin (g/dL) | 0.978 (0.926–1.033) | 0.4297 |
| Platelets (103 U/L) | 0.997 (0.996–0.999) | <0.0001 |
| C-Reactive Protein (mg/dL) | 1.045 (1.034–1.056) | <0.0001 |
| Sodium (mmol/L) | 1.019 (0.996–1.042) | 0.1138 |
| Potassium (mmol/L) | 1.371 (1.135–1.657) | 0.0011 |
Abbreviations: CKD, chronic kidney disease; n, numbers; eGFR, estimated glomerular filtration rate; HR, hazard ratio.